Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125946951 | 12594695 | 1 | I | 201602 | 20160227 | 20160726 | 20160726 | EXP | US-UNITED THERAPEUTICS-UNT-2016-003239 | UNITED THERAPEUTICS | 62.00 | YR | M | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125946951 | 12594695 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.083 ?G/KG, CONTINUING | 2100580 | 21272 | .083 | UG/KG | INJECTION | ||||||
| 125946951 | 12594695 | 2 | SS | LETAIRIS | AMBRISENTAN | 1 | Oral | 5 MG, QD | 40 | MG | SBFS | 0 | 5 | MG | TABLET | QD | |||
| 125946951 | 12594695 | 3 | SS | ADCIRCA | TADALAFIL | 1 | U | U | 0 | ||||||||||
| 125946951 | 12594695 | 4 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 5 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 6 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 7 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 8 | C | MELATONIN | MELATONIN | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 9 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | INHALER | |||||||||||
| 125946951 | 12594695 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125946951 | 12594695 | 13 | C | OXYGEN. | OXYGEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125946951 | 12594695 | 1 | Pulmonary arterial hypertension |
| 125946951 | 12594695 | 2 | Pulmonary arterial hypertension |
| 125946951 | 12594695 | 3 | Product used for unknown indication |
| 125946951 | 12594695 | 4 | Product used for unknown indication |
| 125946951 | 12594695 | 5 | Product used for unknown indication |
| 125946951 | 12594695 | 6 | Product used for unknown indication |
| 125946951 | 12594695 | 7 | Product used for unknown indication |
| 125946951 | 12594695 | 8 | Product used for unknown indication |
| 125946951 | 12594695 | 9 | Product used for unknown indication |
| 125946951 | 12594695 | 10 | Product used for unknown indication |
| 125946951 | 12594695 | 11 | Product used for unknown indication |
| 125946951 | 12594695 | 12 | Product used for unknown indication |
| 125946951 | 12594695 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125946951 | 12594695 | OT |
| 125946951 | 12594695 | DE |
| 125946951 | 12594695 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125946951 | 12594695 | Dyspnoea | |
| 125946951 | 12594695 | Oedema peripheral | |
| 125946951 | 12594695 | Oxygen saturation decreased | |
| 125946951 | 12594695 | Pain in extremity | |
| 125946951 | 12594695 | Paraesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125946951 | 12594695 | 1 | 20151223 | 0 | ||
| 125946951 | 12594695 | 2 | 20160219 | 20160320 | 0 |